Hearing thresholds in children with a congenital CMV infection: A prospective study

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 5, 2012, Pages 712-717

  Foulon, Ina ^a   Naessens, Anne ^a   Faron, Gilles ^a   Foulon, Walter ^a   Jansen, Anna C ^a   Gordts, Frans ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Congenital infection; Cytomegalovirus CMV; Fluctuation; Ganciclovir; Hearing loss

Indexed keywords

GANCICLOVIR;

ARTICLE; ASYMPTOMATIC DISEASE; AUDITORY THRESHOLD; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FOLLOW UP; HEARING LOSS; HEARING LOSS FLUCTUATION; HEARING TEST; HUMAN; INCIDENCE; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; NEUTROPENIA; ONSET AGE; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIMARY INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD;

AUDITORY THRESHOLD; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; HEARING LOSS; HEARING TESTS; HUMANS; INFANT; RISK FACTORS;

EID: 84860251259     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2012.02.026     Document Type: Article

References (20)

1. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 2007, 17(5):355-363.
2. Foulon I., Naessens A., Foulon W., Casteels A., Gordts F. A 10-year prospective study of sensorineural hearing loss in infants with congenital cytomegalovirus infection. J. Pediatr. 2008, 153(1):84-88.
3. Fowler K.B., McCollister F.P., Dahle A.J., Boppana S., Britt W.J., Pass R.F. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediatr. 1997, 130:624-630.
4. Williamson W.D., Demmler G.J., Percy A.K., Catlin F.I. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992, 90:862-866.
5. Foulon I., Naessens A., Foulon W., Casteels A., Gordts F. Hearing loss in children with a congenital cytomegalovirus infection related to the gestational age at which the maternal primary infection occurred. Pediatrics 2008, 122:e1123-e1127.
6. Dahle A.J., Fowler K.B., Wright J.D., Boppana S.B., Britt W.J., Pass R.F. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 2000, 11(5):283-290.
7. Madden C., Wiley S., Schleiss M., Benton C., Meinzen-Derr J., Greinwald J., et al. Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss. Int. J. Pediatr. Otorhinolaryngol. 2005, 69:1191-1198.
8. Naessens A., Casteels A., Decatte L., Foulon W. A serologic strategy for detection neonates at risk for congenital cytomegalovirus infection. J. Pediatr. 2005, 146:194-197.
9. Joint Committee on Infant and Hearing Year 2007 Position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007, 120:898-921.
10. Gordts F., Naessens B., Mudde C.A., Clement P.A.R. Reference data for DPOAE in healthy newborns. Scand. Audiol. 1999, 28:1-5.
11. Bureau for audiophonology (BIAP). BIAP recommendation n°02/1 bis. May 2005. http://www.biap.org/.
12. Brookhouser P.E., Worthington D.W., Kelly W.J. Fluctuating and/or progressive sensorineural hearing loss in children. Laryngoscope 1994, 104. August.
13. Tajudeen B.A., Waltzman S.B., Jethanamest D., Svirsky M.A. Speech perception in congenitally deaf children receiving cochlear implants in the first year of life. Otol. Neurotol. 2010, 31:1254-1260.
14. De Raeve L. A longitudinal study on auditory perception and speech intelligibility in deaf children implanted younger than 18 months in comparison to those implanted at later ages. Otol. Neurotol. 2010, 31:1261-1267.
15. Houston D.M., Miyamoto R.T. Effects of early auditory experience on word learning and speech perception in deaf children with cochlear implants: implications for sensitive periods of language development. Otol. Neurotol. 2010, 31:1248-1253.
16. Kimberlin D.W., Lin C.-Y., Sanchez P.J., Demmler W., Dankner M., Shelton M., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 2003, 143:16-25.
17. Lackner A., Acham A., Alborno T., Moser M., Engele H., Raggam R.B. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. J. Laryngol. Otol. 2009, 123(4):391-396.
18. Royackers L., Desloovere C., Debruyne F., Ermelinde R. Hearing status in children with congenital cytomegalovirus: up-to-6-years audiological follow-up. Int. J. Pediatr. Otorhinolaryngol. 2011, 75:376-382.
19. Amir J., Wolf D.G., Levy I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur. J. Pediatr. 2010, 169(9):1061-1067.
20. Soetens O., Vauloup-Fellous C., Foulon I., Dubreuil P., De Saeger B., Grangeot-Keros L., et al. Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J. Clin. Microbiol. 2008, 46(3):943-946.